Delisted

This security is no longer actively traded. Historical data is preserved for reference.No longer actively traded (Yahoo Finance confirms no newer data)

EFTR

eFFECTOR Therapeutics, Inc.

EFTR·28202V108·UQ·Common Stock·Healthcare - Biotechnology

EFTR (eFFECTOR Therapeutics, Inc.) is held by 2 institutional investors as of Q3 2024. Largest holders: Blackstone Inc. ($2,041), BARCLAYS PLC ($4).

2
Holders
$2,045
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold EFTR.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
52,343$2,0410.0%
0
Unchanged
100$40.0%
0
Exited
0(-100.0%)$10.0%-99.66%
0
Exited
0(-100.0%)$55,9360.0%-99.54%
0
Exited
0(-100.0%)$5,0000.0%-86.21%
0
Exited
0(-100.0%)$700.0%-86.21%
0
Exited
0(-100.0%)$7,4220.0%-99.93%
0
Exited
0(-100.0%)$3,2240.0%-86.21%
0
Exited
0(-100.0%)$17,8830.0%-86.21%
0
Exited
0(-100.0%)$5,4160.0%-86.21%
0
Exited
0(-100.0%)$6,0000.0%-86.21%
0
EFTREFTReFFECTOR Therapeutics, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used